Galya Z.
- Country
- Bulgaria
- Department
- Clinic of Pediatric Nephrology and Dialysis – dialysis treatment
Research Overview
- Safety Evaluation of Long-term Finerenone with ACE Inhibitor or Angiotensin Receptor Blocker in Pediatric Chronic Kidney Disease with Proteinuria
- Evaluation of Finerenone in Combination with ACEI or ARB for Proteinuria and Chronic Kidney Disease in Pediatric Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 66 of 66 partner sites.
Specializations
Inflammatory Bowel Disease and Pediatric Gastroenterology
Galya Zlatanova is involved in clinical research on ulcerative colitis and Crohn’s disease in children, with attention to therapeutic options for active disease and longer-term treatment needs. Her work reflects a strong interest in managing chronic intestinal inflammation in the pediatric setting.
- Vedolizumab for pediatric ulcerative colitis and Crohn’s disease
- Risankizumab in Crohn’s disease
- Upadacitinib for pediatric Crohn’s disease
Her clinical focus includes both active inflammatory disease control and ongoing treatment support for children with chronic gastrointestinal disorders.
Pediatric Nephrology and Kidney Disease
Her research landscape includes chronic kidney disease, proteinuria, and anemia associated with chronic kidney disease, showing a clear therapeutic emphasis on renal complications in children. This area aligns closely with her departmental expertise in dialysis treatment.
- Roxadustat for anemia in pediatric chronic kidney disease
- Finerenone for proteinuria in children with chronic kidney disease
- Chronic kidney disease and related renal support
Her involvement extends to kidney-protective strategies and treatment of renal complications that affect growth, blood parameters, and long-term pediatric outcomes.
Pediatric Endocrinology and Growth Disorders
Galya Zlatanova is active in studies addressing impaired growth in children, including short stature linked to small for gestational age, Turner syndrome, Noonan syndrome, and idiopathic short stature. Her therapeutic interest also includes metabolic conditions affecting body weight.
- Somapacitan in children with growth disorders
- Obesity and type 2 diabetes
- CagriSema and cagrilintide for weight management
Her research profile covers both linear growth support and interventions for excess body weight in pediatric populations.
Pediatric Rheumatology and Immune-Mediated Disease
Her clinical trial activity includes polyarticular-course juvenile idiopathic arthritis, highlighting interest in inflammatory joint disease in children and adolescents. This area places her within pediatric immune-mediated therapeutic research.
- Filgotinib in polyarticular-course juvenile idiopathic arthritis
- Inflammatory joint disease in pediatric patients
Her work supports the evaluation of targeted therapies for chronic rheumatologic disease in younger patients.
Pediatric Neurology and Functional Gastrointestinal Disorders
Her research interests also span refractory partial onset epilepsy and functional constipation, indicating involvement in both neurologic and motility-related pediatric conditions. These areas broaden her therapeutic portfolio beyond renal and inflammatory disease.
- Levetiracetam in drug-resistant focal onset seizures
- Linaclotide for functional constipation
Her clinical activity includes treatment-focused research for seizure control and bowel function disorders in children.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.